Owing to heterogeneity and variation in the dosage employed across studies, the dosage was divided into low-dose (less than 300 mg/day) and high-dose (greater than 300 mg/day) pregabalin. If studies provided different dosages, the results were reported separately for each dosage type rather than in combination. Sampling in the original study 26 was carried out by means of a stratified multistage probabilistic sample without replacement. The sampling frame was all health regions from the 17 autonomous communities of Spain. The first pregabalin for sale stage consisted of the selection of the PCS within each health region.
Pregabalin: The Wonder Drug at Your Fingertips
Moreover, because we only licensed value and volume sales data and not patient-level data, we were only able to capture population-level trends, making it difficult to determine whether individuals who reduced pregabalin use switched to gabapentin or opioids. Additionally, this study used an ecological interrupted time series design, which evaluates aggregate-level trends in drug utilization over time rather than individual-level behavior. While this approach is robust for assessing policy impacts, it relies on several key assumptions, including a stable underlying population, no concurrent external interventions, and no time-varying confounders during the study period. Although no other major regulatory or clinical policy changes occurred at the time of the pregabalin policy implementation, it is important to acknowledge these underlying assumptions and the inherent limitations of this design. Lastly, this study focuses on drug volume sales trends rather than clinical outcomes, preventing direct assessment of changes in overdose rates, adverse events, or treatment efficacy.
- The term refractory was defined as the absence of pain reduction after treatment with at least one course of an analgesic drug in monotherapy.
- Respondents indicated that maximum daily doses ranged from 1,500 to 9,000 mg, which significantly exceeded the dose taken when they first used the drug (150 to 750 mg).
- In the PHN patient population, treatment with pregabalin had 9.6 additional days of mild/no pain at $429 additional cost, resulting in an incremental cost per additional day of mild/no pain of $44.74.
- Leading players are expanding strategic partnerships, optimizing distribution networks, and investing in talent development to support long-term growth.
Your doctor may want you or your child to gradually reduce the amount you are taking before stopping it completely. Stopping the medicine suddenly may cause seizures or side effects including changes in behavior, dizziness, diarrhea, nausea, headaches, vomiting, irritability, thoughts of killing oneself, trouble with sleeping, nightmares, or tingling feelings. Pregabalin is used with other medicines to help control partial-onset seizures (convulsions) in the treatment of epilepsy in patients 1 month of age and older. This medicine will not cure epilepsy and will only work to control seizures for as long as you continue to take it.
Blockchain In Digital Rights Management Market Size: Revenue Growth & Investment Trends 2026-2033
Regulatory frameworks can be opaque; cultural and linguistic localization is critical. Channels include government procurement, regional distributors, and expanding digital ecosystems in major cities. As the largest and most established neurosurgical practice in Oklahoma, we have a long history of state-of-the-art, patient-focused treatment for neurological problems. In 1948, we have grown from a practice with just three doctors to having seven physicians dedicated to providing the best in neurosurgical treatments to Oklahoma City and beyond. FDB disclaims all warranties, whether expressed or implied, including any warranty as to the quality, accuracy, and suitability of this information for any purpose. Use our drug comparison tool to perform a side by side comparisons of Pregabalin and other medications.
Your doctor may combine two or more therapies to maximize the success of your treatment. Local pharmacies negotiate directly with wholesalers and pay different dispensing fees. Independent pharmacies often carry higher overhead but may offer loyalty discounts or cash-pay programs. Large chains use formulary contracts that prioritize volume over individual patient needs—sometimes placing effective generics on non-preferred tiers to steer toward higher-margin brands.